Literature DB >> 19110228

A comparison of younger vs older women with vulvar cancer in the United States.

Sanjeev Kumar1, Jay P Shah, Christopher S Bryant, Anthony N Imudia, Robert T Morris, John M Malone.   

Abstract

OBJECTIVE: The purpose of this study was to compare the prognostic variables and survival of younger (< 50 years) to that of older (> or = 50 years) women with vulvar cancer. STUDY
DESIGN: Subjects with invasive squamous cell carcinoma of the vulva were identified from the limited use Surveillance, Epidemiology, and End Results (SEER) Program 1988-2005. Comparisons between younger and older women were accomplished with chi(2) and t-tests. Survival analysis was accomplished with Kaplan-Meier for univariate analysis and Cox proportional hazards model for multivariate analysis.
RESULTS: A total of 6965 patients met inclusion criteria, of whom 1345 patients (19.3%) were younger and 5620 patients (80.7%) were older. The 5-year survival was 87.5% for younger women and 52.5% for older women (P < .001). After data were controlled for race, stage, grade, and surgical treatment, older patients had a hazard ratio of 3.9 (95% CI, 3.2-4.7) for death.
CONCLUSION: A striking survival difference exists between younger and older women with squamous cell vulvar cancer, which supports the view that etiopathogenesis of this disease may vary between age groups.

Entities:  

Mesh:

Year:  2008        PMID: 19110228     DOI: 10.1016/j.ajog.2008.09.869

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

1.  Pathologic features of aggressive vulvar carcinoma are associated with epithelial-mesenchymal transition.

Authors:  Emily R Holthoff; Horace Spencer; Thomas Kelly; Steven R Post; Charles M Quick
Journal:  Hum Pathol       Date:  2016-06-18       Impact factor: 3.466

2.  Effect of age and comorbidity on the treatment and survival of older patients with vulvar cancer.

Authors:  Rahel G Ghebre; Rebecca Posthuma; Rachel Isaksson Vogel; Melissa A Geller; Linda F Carson
Journal:  Gynecol Oncol       Date:  2011-03-12       Impact factor: 5.482

3.  Small-area analysis of incidence and localisation of vulvar cancer.

Authors:  Klaus H Baumann; Olga Müller; Helke B Naujok; Ellen Mann; Peter Barth; Uwe Wagner
Journal:  J Oncol       Date:  2010-06-22       Impact factor: 4.375

4.  Prognostic significance of c-KIT in vulvar cancer: bringing this molecular marker from bench to bedside.

Authors:  Beatriz de Melo Maia; André Mourão Lavorato-Rocha; Iara Sant'ana Rodrigues; Glauco Baiocchi; Flávia Munhoz Cestari; Monica Maria Stiepcich; Ludmila Thomé Domingues Chinen; Kátia C Carvalho; Fernando Augusto Soares; Rafael Malagoli Rocha
Journal:  J Transl Med       Date:  2012-07-28       Impact factor: 5.531

5.  Epithelial-mesenchymal transition-like events in vulvar cancer and its relation with HPV.

Authors:  I S Rodrigues; A M Lavorato-Rocha; B de M Maia; M M A Stiepcich; F M de Carvalho; G Baiocchi; F A Soares; R M Rocha
Journal:  Br J Cancer       Date:  2013-06-18       Impact factor: 7.640

6.  A Very Rare Case: HPV-Negative Vulvar Cancer in an Adolescent.

Authors:  Ilker Kahramanoglu; Hasan Turan; Yahya Ozgun Oner; Tugan Bese; Sennur Ilvan; Macit Arvas; Fuat Demirkiran
Journal:  Case Rep Obstet Gynecol       Date:  2018-02-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.